Evolution of the Average Target: Charles River Laboratories International, Inc.

Evolution of the Average Target - Charles River Laboratories International, Inc.

Evolution of the Target Price: Charles River Laboratories International, Inc.

Evolution of the Target Price - Charles River Laboratories International, Inc.

Changes in Analyst Recommendations: Charles River Laboratories International, Inc.

d34fdddfded15.TDNY1URcNDfYN0D0y4CVr1VGoLnSyMy3HvEpa6ggpOQ.C0kunikfV3yhQAeGj6365WIkxPfmvo7yS6ZYWcVB6pMnVi2NDgZTfI9CdA~85cab5d39f91bd9615076d9a8e508fb3
30/09 UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175 MT
28/09 Jefferies Adjusts PT on Charles River Laboratories International to $340 From $305, Maintains Buy Rating MT
26/09 Charles River Laboratories's DAS Segment Faces Largest Margin Upside, RBC Says MT
25/09 Deutsche Bank Raises Price Target on Charles River Laboratories International to $320 From $300, Keeps Buy Rating MT
25/09 RBC Raises Price Target on Charles River Laboratories International to $322 From $282, Keeps Outperform Rating MT
25/09 Evercore ISI Adjusts PT on Charles River Laboratories International to $330 From $320, Maintains Outperform Rating MT
25/09 Mizuho Adjusts PT on Charles River Laboratories International to $295 From $264, Keeps Neutral Rating MT
25/09 Barclays Adjusts PT on Charles River Laboratories International to $330 From $300, Keeps Overweight Rating MT
25/09 TD Cowen Adjusts PT on Charles River Laboratories International to $325 From $300, Maintains Buy Rating MT
25/09 Baird Adjusts PT on Charles River Laboratories International to $334 From $291, Keeps Outperform Rating MT
17/09 Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating MT
11/09 Evercore ISI Adjusts PT on Charles River Laboratories International to $320 From $300, Maintains Outperform Rating MT
10/08 TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating MT
10/08 Rothschild & Co Redburn Adjusts PT on Charles River Laboratories International to $318 From $241, Maintains Buy Rating MT
07/08 Barclays Adjusts Price Target on Charles River Laboratories International to $300 From $220 MT
06/08 RBC Adjusts PT on Charles River Laboratories International to $282 From $215, Keeps Outperform Rating MT
06/08 Deutsche Bank Adjusts Charles River Laboratories International PT to $300 From $260, Maintains Buy Rating MT
06/08 Analyst recommendations: AppLovin, Emerson Electric, Roblox, Flutter Entertainment, HubSpot... Zonebourse
06/08 JPMorgan Upgrades Charles River Laboratories International to Overweight From Neutral, Adjusts PT to $310 From $180 MT
20/07 Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… Zonebourse
14/07 BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 MT
14/07 Baird Adjusts Charles River Laboratories International Price Target to $255 From $213, Maintains Outperform Rating MT
13/07 Mizuho Adjusts Price Target on Charles River Laboratories International to $230 From $192, Maintains Neutral Rating MT
10/07 Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $260 From $220 MT
07/07 Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+2.9%
+20.88%
+39.25%
+20.5%
+13.53%
+36.56%
+22.87%
+49.08%
+10.4%
+19.76%
Average +23.57%
Weighted average by Cap. +24.98%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
301.79USD
Average target price
310.53USD
Spread / Average Target
+2.90%
High Price Target
357.00USD
Spread / Highest target
+18.29%
Low Price Target
145.00USD
Spread / Lowest Target
-51.95%

Analyst Consensus Detail

Analyst consensus - Charles River Laboratories International, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Charles River Laboratories International, Inc.
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Charles River Laboratories International, Inc.
  1. Stock Market
  2. Stocks
  3. CRL Stock
  4. Consensus Charles River Laboratories International, Inc.